Page last updated: 2024-08-21

quinazolines and Scleroderma, Systemic

quinazolines has been researched along with Scleroderma, Systemic in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (22.22)	18.7374
1990's	1 (11.11)	18.2507
2000's	6 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bona, CA; Kodera, T; McGaha, TL; Pines, M; Spiera, H; Stan, AC	1
Bona, C; Kodera, T; McGaha, T; Phelps, R; Pines, M; Spiera, H	1
Nagler, A; Pines, M; Snyder, D; Yarkoni, S	1
Kakizoe, E; Okunishi, H; Shimoura, K; Shiota, N; Tanaka, T	1
Allen, LM; Duvic, M; Gilgor, RS; Surwit, RS	2
Sule, SD; Wigley, FM	1
Black, CM; Denton, CP	1
Nishioka, K; Yamamoto, T	1

Reviews

3 review(s) available for quinazolines and Scleroderma, Systemic

Article	Year
Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2003, Volume: 9, Issue:7 Topics: Administration, Cutaneous; Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Collagen Type I; Fibrosis; Graft vs Host Disease; Humans; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Scleroderma, Systemic	2003
Novel therapy in the treatment of scleroderma. Expert opinion on investigational drugs, 2001, Volume: 10, Issue:1 Topics: Autoimmune Diseases; Bone Marrow Transplantation; Cysteine; Humans; Interferon-gamma; Nitric Oxide; Piperidines; Prostaglandins; Quinazolines; Quinazolinones; Relaxin; Scleroderma, Systemic; Tetracycline; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2001
Novel therapeutic strategies in scleroderma. Current rheumatology reports, 1999, Volume: 1, Issue:1 Topics: Clinical Trials as Topic; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Minocycline; Nitric Oxide; Piperidines; Prognosis; Quinazolines; Quinazolinones; Relaxin; Scleroderma, Systemic; Treatment Outcome	1999

Trials

1 trial(s) available for quinazolines and Scleroderma, Systemic

Article	Year
A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma. Archives of dermatology, 1984, Volume: 120, Issue:3 Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Prazosin; Quinazolines; Raynaud Disease; Scleroderma, Systemic	1984

Other Studies

5 other study(ies) available for quinazolines and Scleroderma, Systemic

Article	Year
Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism. Arthritis and rheumatism, 2002, Volume: 46, Issue:10 Topics: Administration, Topical; Animals; Cells, Cultured; Collagen; Collagen Type I; Drug Synergism; Fibroblasts; Gene Expression; Male; Mice; Mice, Mutant Strains; Mitogens; Phosphorylation; Piperidines; Promoter Regions, Genetic; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-jun; Quinazolines; Quinazolinones; RNA, Messenger; Scleroderma, Systemic; Transcription Factor AP-1; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Effect of halofuginone on the development of tight skin (TSK) syndrome. Autoimmunity, 2002, Volume: 35, Issue:4 Topics: Animals; Animals, Newborn; Collagen; Disease Models, Animal; Fibrosis; Humans; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Scleroderma, Systemic; Skin Diseases	2002
Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice. British journal of pharmacology, 2005, Volume: 145, Issue:4 Topics: Animals; Cell Proliferation; Chymases; Fibrosis; Immunohistochemistry; Mast Cells; Mice; Mice, Inbred C57BL; Protease Inhibitors; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Scleroderma, Systemic; Serine Endopeptidases; Skin; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
The combined effect of prazosin and autogenic training on cold reactivity in Raynaud's phenomenon. Biofeedback and self-regulation, 1982, Volume: 7, Issue:4 Topics: Adult; Autogenic Training; Blood Pressure; Cold Temperature; Female; Fingers; Humans; Male; Middle Aged; Prazosin; Quinazolines; Raynaud Disease; Scleroderma, Systemic; Skin; Skin Temperature	1982
Analysis of the effect of halofuginone on bleomycin-induced scleroderma. Rheumatology (Oxford, England), 2002, Volume: 41, Issue:5 Topics: Animals; Bleomycin; Collagen; Disease Models, Animal; Female; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Scleroderma, Systemic; Specific Pathogen-Free Organisms; Treatment Outcome	2002